Bank Mandiri (BMRI IJ) (Buy) - 9M24 – Steady growth
NS EWBMRI released its 9M24 results on 30 October, with the company remaining on a steady growth trajectory.
BMRI released its 9M24 results on 30 October, with the company remaining on a steady growth trajectory.
In our recent note, we wrote that BBRI might face maturing micro/ultra-micro segments in the next few years.
BRIS continued to deliver solid 3Q24 bottom line performance with the numbers coming in largely in-line with o
BBNI released its 9M24 results with headline profit at IDR16.3tn (+3.3% y-y),
Despite the anticipated rate cut cycle, we believe Indonesia banks have limited room to lower their cost of fu
We took a closer look at BMRI’s provisioning expenses (12MMA CoC) which has stabilised at ~70-80bp in 1H24.
According to recent news (LINK 1), the government is looking to provide debt forgiveness for written-off loans
BBCA released its 9M24 results with headline profit at IDR41.1tn (+13% y-y) accounting for ~78% of our FY24F p
Despite recent Bank Indonesia’s (BI) benchmark rate cut, funding costs may continue to inch higher
Below, we present two charts (Fig. 1 and Fig. 2) depicting the loan-to-CASA and loan-to-saving trends across I
On a YTD basis, BBRI had underperformed its major peers by ~13-30%, with predominantly net foreign selling amo
Major Indonesia banks (BBCA/BMRI/BBRI/BBNI) have published their bank-only Aug-24 results,
BRIS has released its YTD Aug-24 results, which came in largely inline with our projections.
BBNI has released its bank-only YTD Aug-24 results, which suggest limited operating improvements for the bank.
On a YTD basis, BBRI’s share price has underperformed its peers (BMRI / BBCA / BBNI / BRIS – all Buys)